IBNCX
Price
$24.91
Change
-$0.01 (-0.04%)
Updated
Sep 5 closing price
Net Assets
2.04B
RLBCX
Price
$37.73
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
259.11B
Interact to see
Advertisement

IBNCX vs RLBCX

Header iconIBNCX vs RLBCX Comparison
Open Charts IBNCX vs RLBCXBanner chart's image
Macquarie Balanced Fund
Price$24.91
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets2.04B
American Funds American Balanced R3
Price$37.73
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets259.11B
IBNCX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBNCX vs. RLBCX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 259B vs. IBNCX (2.04B). RLBCX pays higher dividends than IBNCX: RLBCX (1.53) vs IBNCX (0.49). IBNCX was incepted earlier than RLBCX: IBNCX (22 years) vs RLBCX (23 years). IBNCX (1.83) is less costly to investors than RLBCX (0.89). IBNCX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than IBNCX: RLBCX (250) vs IBNCX (1000). IBNCX annual gain was more profitable for investors over the last year : 11.39 vs. RLBCX (9.58). RLBCX return over 5 years is better than : 37.90 vs. IBNCX (2.35).
IBNCXRLBCXIBNCX / RLBCX
Total Expense Ratio1.810.89203%
Annual Report Gross Expense Ratio1.830.89206%
Fund Existence22 years23 years-
Gain YTD8.45211.12776%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B259B1%
Annual Yield % from dividends0.491.5332%
Returns for 1 year11.399.58119%
Returns for 3 years13.0538.7234%
Returns for 5 years2.3537.906%
Returns for 10 years6.9072.0210%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRVCF0.02N/A
+13.10%
PreveCeutical Medical Inc.
AIQUY41.130.03
+0.07%
L'Air Liquide SA
SSMXF12.50N/A
N/A
Sysmex Corp.
PRMY26.99N/A
N/A
Primary Bk
OKCTF27.88N/A
N/A
Okinawa Cellular Telephone Co., Ltd.